Your Guide to Important Ibogaine Treatment Screening Criteria

Why ibogaine treatment screening criteria matter

If you are looking into ibogaine for addiction or mental health concerns, understanding ibogaine treatment screening criteria is essential. Ibogaine is a powerful medicine with real medical risks, especially to your heart and nervous system. Safe programs do not offer it to everyone. Instead, they use detailed medical and psychological screening to decide who qualifies and how treatment should be structured.

By learning how reputable clinics screen candidates, you can better understand where you might fit, what tests you should expect, and when ibogaine may not be appropriate or safe. This guide walks you through key ibogaine treatment screening criteria so you can have more informed conversations with providers and protect your health.

If you want to go deeper on related topics, you can also explore resources such as ibogaine treatment eligibility requirements and who qualifies for ibogaine therapy.

Core goals of ibogaine treatment screening

Screening for ibogaine therapy is not a formality. It has several important purposes that directly affect your safety and your chances of a good outcome.

First, screening is used to identify whether you are medically and psychologically stable enough to tolerate ibogaine. The medicine can slow your heart rate, affect your blood pressure, and prolong the QT interval on your electrocardiogram. These effects can provoke life‑threatening arrhythmias in people with certain heart conditions or those taking specific medications [1].

Second, screening helps your medical team tailor dosing and monitoring to your individual risk profile. Factors like your liver function, kidney function, and CYP2D6 metabolism influence how your body processes ibogaine, so safe dosing varies from person to person [2].

Finally, screening assesses your motivation and consent. Ethical programs only work with people who are seeking ibogaine voluntarily and who understand both the potential benefits and the serious risks involved [3].

Informed consent and personal readiness

One of the first ibogaine treatment patient requirements is your clear, voluntary consent. Guidelines emphasize that you should not be coerced by family, courts, or external pressures into ibogaine therapy. You need to show a genuine desire to participate and a willingness to engage in the therapeutic process, not just a wish for a quick fix [2].

Reputable providers usually ask you to:

Review and sign a written informed consent document in person with a staff witness, and in some cases by verified video, confirming you understand the known risks and benefits
[4]
Disclose your full medical and psychiatric history honestly
Discuss your motivation, treatment goals, and expectations

Centers like the Avante Institute also require that you agree to a general medical evaluation with a local physician before you arrive at the clinic, which further confirms your understanding and readiness [5].

On the psychological side, some programs include tools such as the Beck Depression Inventory or structured interviews to gauge your mental health status and your ability to benefit from the experience [5].

If you are at the stage of asking whether this therapy is something you truly want to pursue, it may help to read more about who should consider ibogaine therapy.

Medical history and health information collection

A thorough health intake is central to ibogaine therapy health requirements. Before anyone clears you for treatment, you can expect to be asked for comprehensive personal and medical information, including:

Past and current diagnoses
Detailed substance use history
All current and recent medications, including over‑the‑counter and herbal products
Prior heart, neurological, or psychiatric issues
Surgical history and hospitalizations

Clinical guidelines recommend collecting a detailed drug use profile that includes the types of substances, doses, frequency, and patterns, along with any history of overdose or withdrawal complications [2]. This data helps clinicians anticipate withdrawal needs and plan detox safely.

Programs like Bassé Clinic, Beond, Oceanside, and Avante all emphasize rigorous pre‑screening to filter out high‑risk cases and to design safer, individualized ibogaine treatment plans [6].

Essential medical tests before ibogaine therapy

Safe ibogaine treatment screening criteria go beyond paperwork. You should expect a series of diagnostic tests designed to evaluate your heart, liver, kidneys, and general health.

Cardiac testing and monitoring

Because ibogaine can slow the heart and prolong the QT interval, cardiac evaluation is non‑negotiable. Standard screening typically includes:

Electrocardiogram (ECG or EKG) before admission, and again on arrival at the clinic to confirm results and apply exclusion criteria [4]
In some cases, an echocardiogram when you or your family has a history of cardiac issues, since some problems may not appear on a standard EKG or stress test [5]

On treatment day, clinics such as Bassé repeat the EKG to reassess your readiness and may use continuous or periodic cardiac monitoring during the acute phase to reduce the risk of arrhythmia [7].

Clinical guidelines also recommend:

Continuous 3‑lead heart monitoring for at least 12 to 24 hours after dosing, with an ACLS‑trained staff member present at all times and a second person on hand for emergencies, until T‑wave morphology normalizes for at least one hour [8]
Ongoing blood pressure, pulse, and oxygen saturation monitoring every 4 hours while you are awake for at least 72 hours after treatment, with emergency‑trained staff available because cardiac risk does not end when the visions stop [8]

Blood work and chemistry panels

Blood tests are central to medical requirements for ibogaine therapy. You can expect at least:

Complete blood count (CBC)
Comprehensive metabolic panel (CMP) to evaluate liver and kidney function, electrolytes, and glucose
Additional chemistry tests as needed

Guidelines advise repeating blood tests if previous results are older than 14 days before ibogaine administration to ensure your current status is known [4].

Centers such as Bassé and Oceanside rely on blood chemistry panels to identify liver or kidney impairment and to monitor electrolyte levels continuously, since imbalances increase cardiac risk during ibogaine treatment [9].

Urine testing and substance screening

Urinalysis serves several purposes in ibogaine therapy candidate screening:

Detecting pregnancy
Identifying benzodiazepines, buprenorphine, and alcohol metabolites (EtG and EtS)
Checking for other substances that might interact dangerously with ibogaine

Guidelines recommend using GCMS or GCLS tests where possible, since many synthetic substances are not detected by standard ELISA panels. Results usually return within 24 hours [4].

Some centers also use urine drug tests to verify that you have complied with pre‑treatment instructions about stopping certain medications or substances that could prolong the QT interval or increase serotonin [10].

Medication and substance restrictions before treatment

Many ibogaine treatment screening criteria focus on what you are taking before you arrive. Certain medications and substances can significantly raise your risk of heart problems or serotonin syndrome if combined with ibogaine.

According to clinical guidance, you should avoid or be carefully evaluated if you are taking:

QT‑prolonging medications
Diuretics and centrally acting drugs
Heart rhythm medications and some calcium channel blockers or beta blockers
Serotonin‑increasing drugs such as SSRIs, SNRIs, and MAOIs
Some antibiotics and antipsychotics that affect cardiac conduction
Substances and medications that inhibit CYP2D6, such as paroxetine or grapefruit products

These drugs and interactions are a major reason you need to disclose every prescription, supplement, and recreational substance you use. Providers often require a washout period, sometimes under medical supervision, to reduce your risk before dosing [11].

Alcohol use is another specific issue. For people who drink regularly, one guideline references a medically supervised detox of at least 12 days before ibogaine, primarily to protect your liver and reduce the chance of severe withdrawal during treatment [10].

If you are trying to understand where your own medications or substances fit, it can help to review ibogaine therapy health requirements and discuss them with a medically trained provider.

Physical health exclusion criteria

You might not be eligible for ibogaine therapy if you have certain medical conditions. These exclusions are not meant to gatekeep. They exist because the combination of ibogaine and specific health issues can be deadly.

Absolute or strong exclusion criteria commonly include:

Significant heart disease, including:
History of heart attack, heart murmurs, arrhythmias, or heart operations
Uncontrolled hypertension
Structural heart disease
Marked QT prolongation at baseline
[1]
Major respiratory conditions
Severe or chronic gastrointestinal disease, such as peptic ulcer disease or Crohn’s disease [12]
Significant liver or kidney impairment
Body mass index over 35
Unstable diabetes, thyroid disorders, or severe anemia
Active infections such as HIV, hepatitis, or tuberculosis
[13]

Pregnancy is a clear exclusion in many programs, as the risks to the fetus are not ethically acceptable. Abnormal lab values that fall outside standard ranges can also disqualify you, at least until they are investigated and stabilized [5].

Some clinics, such as Bassé, explicitly exclude people with active diseases affecting the heart, lungs, or liver, which reflects the central role of these organs in ibogaine metabolism and safety [7].

To see how these factors might apply to you, you can compare them with the information in who can receive ibogaine therapy.

Psychiatric and neurological safety considerations

Your mental health history is as important as your physical health when it comes to ibogaine treatment screening criteria. Ibogaine affects perception, cognition, and mood. For some people this is healing. For others it can trigger destabilization.

Guidelines and clinical experience generally exclude:

Active psychotic disorders
Schizophrenia or past psychotic episodes
Severe bipolar disorder
Certain severe depressive disorders that require specific high‑risk medications
Epilepsy or a history of seizures

Ibogaine can lower seizure threshold and can worsen or unmask psychotic symptoms in people vulnerable to these conditions. As a result, individuals with such diagnoses typically do not qualify for ibogaine treatment unless risks can be clearly mitigated, which is rare [14].

High‑quality programs supplement this risk assessment with psychological evaluations on arrival, checking for:

Current suicidality
Severe anxiety or instability that might interfere with the process
Trauma history that may require additional support

Clinics such as Bassé include trauma‑informed psychological support, somatic therapies, and bodywork as part of treatment, which supports mental and emotional safety during and after the ibogaine experience [7].

Hydration, electrolytes, and pre‑treatment preparation

Even if you meet the main eligibility criteria, your body needs to be prepared for ibogaine. Hydration and electrolyte balance are crucial parts of this process.

Clinical guidelines recommend that before ibogaine treatment you:

Begin intensive hydration with fluids containing electrolytes, such as coconut water, about 24 hours before dosing
Aim for approximately 1 fluid ounce of electrolyte‑containing fluid per kilogram of body weight over the day, and continue for at least 72 hours after treatment [8]

On top of oral hydration, clinics like Bassé may provide:

Oral and intravenous supplementation of magnesium, sodium chloride, calcium, phosphorus, and potassium
Frequent lab checks and vital signs monitoring to keep electrolyte levels within safe ranges during treatment [7]

Another standard requirement is fasting. To reduce nausea, vomiting, and the risk of losing medicine, you are generally asked not to eat for 8 to 12 hours before the ibogaine dose, while still focusing on healthy eating in the days leading up to treatment [8].

You may also notice that some programs encourage you to avoid stimulants and caffeine for at least five days before dosing, mainly to lower cardiac strain and avoid confounding withdrawal symptoms [10].

On‑site screening and stabilization on arrival

Even after you complete remote pre‑screening and arrive at a clinic, ibogaine treatment screening criteria continue. Safe centers repeat and expand assessments to make sure nothing has changed.

Typical intake procedures include:

Repeat ECG to confirm previous results and reassess risk
Repeat or updated blood tests if necessary
Physical examination and vital signs check
Review of your clinical history and any interim changes since initial screening [4]

Guidelines also recommend that you surrender all medications, food, drugs, and potentially distracting electronics during intake. This step is not about punishment. It is meant to prevent unreported substance use that could interact with ibogaine, while staff are instructed to conduct searches as respectfully as possible to maintain trust [4].

Some programs, such as Oceanside, structure your stay as an 8‑day inpatient program with:

About five days of detox and preparation
One day of ibogaine dosing
Two days of close post‑treatment monitoring and discharge planning

This design reflects the need for slow, medically supervised stabilization before and after the actual ibogaine session [15].

What supervised ibogaine programs look for in a candidate

When you look at all these criteria together, a general profile emerges of who is more likely to be accepted into a supervised ibogaine program. In broad terms, clinics often look for someone who:

Is seeking treatment voluntarily and understands the risks
Has a diagnosable substance use disorder or treatment‑resistant mental health condition that may respond to ibogaine
Is between early adulthood and older age, with a body mass index under 35
Has stable cardiovascular, liver, and kidney function
Is not pregnant and does not have major respiratory, gastrointestinal, or infectious disease
Has no history of psychotic disorders, uncontrolled bipolar disorder, or seizures
Can safely discontinue contraindicated medications under medical supervision
Is willing to stay in a monitored residential setting for preparation, dosing, and aftercare

Programs like Oceanside even specify inclusion criteria in research contexts, for example adults 18 or older with methamphetamine use disorder, daily use within a defined range, and use duration between one and six years [15].

If you recognize yourself in this description, you may fall within the group of people who is eligible for ibogaine detox, provided detailed medical screening confirms it. If not, there may still be other effective treatment options better suited to your health profile.

For more structured guidance, you can review who is eligible for ibogaine detox and ibogaine treatment patient requirements.

Aftercare, monitoring, and ongoing safety

Ibogaine therapy does not end when the main effects wear off. Continuous medical supervision and aftercare are part of responsible ibogaine treatment screening criteria because risks can persist for days.

Post‑treatment protocols often include:

Extended observation with regular checks of blood pressure, heart rate, and oxygen levels for at least 72 hours after dosing [8]
Access to ACLS‑trained staff and emergency equipment throughout your stay
Gradual reintroduction of food and gentle activity based on how your body responds
Follow‑up medical evaluations and therapeutic coaching to help you integrate the experience into ongoing recovery, as highlighted by providers like Beond [16]

Centers such as Oceanside also emphasize strict protection of your privacy and confidentiality, which can be an important factor if you worry about stigma around your treatment [15].

Key idea: Ibogaine is not a stand‑alone cure. It is a powerful intervention that must be surrounded by careful screening, medical monitoring, and long‑term recovery planning.

Using screening criteria to make your decision

Understanding ibogaine treatment screening criteria helps you in several ways. You can:

Assess whether ibogaine is realistically safe for you before investing time or money
Recognize red flags in programs that skip or minimize these medical steps
Prepare accurate health information and questions for potential providers
Decide whether you prefer to pursue ibogaine now, address health issues first, or consider alternative treatments

If you are ready to compare your situation with typical inclusion and exclusion factors, you might find it helpful to look at ibogaine therapy candidate screening and medical requirements for ibogaine therapy.

Whatever you decide, your safety comes first. Use these criteria not only to see if you qualify, but also to evaluate whether any clinic you are considering is operating with the level of care that this medicine demands.